Cargando…

Albumin Lipidomics Reveals Meaningful Compositional Changes in Advanced Cirrhosis and Its Potential to Promote Inflammation Resolution

Albumin infusions are therapeutically used to revert hypoalbuminemia and to replace the extensively oxidized albumin molecule circulating in patients with acutely decompensated (AD) cirrhosis. Because albumin has high affinity for lipids, here we characterized the albumin lipidome in patients with A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Casulleras, Mireia, Flores‐Costa, Roger, Duran‐Güell, Marta, Zhang, Ingrid W., López‐Vicario, Cristina, Curto, Anna, Fernández, Javier, Arroyo, Vicente, Clària, Joan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134813/ https://www.ncbi.nlm.nih.gov/pubmed/35178899 http://dx.doi.org/10.1002/hep4.1893

Ejemplares similares

Leukocytes, Systemic Inflammation and Immunopathology in Acute-on-Chronic Liver Failure
por: Casulleras, Mireia, et al.
Publicado: (2020)

Stimulation of soluble guanylate cyclase exerts antiinflammatory actions in the liver through a VASP/NF-κB/NLRP3 inflammasome circuit
por: Flores-Costa, Roger, et al.
Publicado: (2020)

The soluble guanylate cyclase stimulator IW‐1973 prevents inflammation and fibrosis in experimental non‐alcoholic steatohepatitis
por: Flores‐Costa, Roger, et al.
Publicado: (2018)

Small fragments of hyaluronan are increased in individuals with obesity and contribute to low-grade inflammation through TLR-mediated activation of innate immune cells
por: Romo, Mònica, et al.
Publicado: (2022)

Albumin in decompensated cirrhosis: new concepts and perspectives
por: Bernardi, Mauro, et al.
Publicado: (2020)

Mitochondrial Dysfunction in Advanced Liver Disease: Emerging Concepts
por: Zhang, Ingrid W., et al.
Publicado: (2021)

Reduced Plasma Extracellular Vesicle CD5L Content in Patients With Acute-On-Chronic Liver Failure: Interplay With Specialized Pro-Resolving Lipid Mediators
por: Sánchez-Rodríguez, María Belen, et al.
Publicado: (2022)

Association of a variant in the gene encoding for ERV1/ChemR23 with reduced inflammation in visceral adipose tissue from morbidly obese individuals
por: López-Vicario, Cristina, et al.
Publicado: (2017)

Resolution of Acute Inflammation and the Role of Lipid Mediators
por: Clària, Joan
Publicado: (2010)

Roles of systemic inflammatory and metabolic responses in the pathophysiology of acute-on-chronic liver failure
por: Clària, Joan, et al.
Publicado: (2023)

Resolution of inflammation in obesity-induced liver disease
por: Rius, Bibiana, et al.
Publicado: (2012)

Resolution of Adipose Tissue Inflammation
por: González-Périz, Ana, et al.
Publicado: (2010)

Pseudocholinesterase and albumin in infants with cirrhosis
por: Popoviê, LJ, et al.
Publicado: (2000)

HIGH RESOLUTION MASS SPECTROMETRY IN LIPIDOMICS
por: Züllig, Thomas, et al.
Publicado: (2020)

Human albumin in the management of complications of liver cirrhosis
por: Bernardi, Mauro, et al.
Publicado: (2012)

New Insights into the Role of Macrophages in Adipose Tissue Inflammation and Fatty Liver Disease: Modulation by Endogenous Omega-3 Fatty Acid-Derived Lipid Mediators
por: Clària, Joan, et al.
Publicado: (2011)

The cost-effectiveness of albumin in the treatment of decompensated cirrhosis in Germany, Italy, and Spain
por: Runken, M. Chris, et al.
Publicado: (2019)

Hepatic inflammasome activation as origin of Interleukin-1α and Interleukin-1β in liver cirrhosis
por: Praktiknjo, Michael, et al.
Publicado: (2021)

Differential inflammasome activation predisposes to acute-on-chronic liver failure in human and experimental cirrhosis with and without previous decompensation
por: Monteiro, Sofia, et al.
Publicado: (2021)

Immune Dysfunction and Albumin-Related Immunity in Liver Cirrhosis
por: Wilde, Benjamin, et al.
Publicado: (2019)

Role of albumin in cirrhosis: from a hospitalist’s perspective
por: Walayat, Saqib, et al.
Publicado: (2017)

Correction to: The cost-effectiveness of albumin in the treatment of decompensated cirrhosis in Germany, Italy, and Spain
por: Runken, M. Chris, et al.
Publicado: (2020)

An investigation of the resolution of inflammation (catabasis) in COPD
por: Noguera, Aina, et al.
Publicado: (2012)

Characterization of Blood Immune Cells in Patients With Decompensated Cirrhosis Including ACLF
por: Weiss, Emmanuel, et al.
Publicado: (2021)

High-Resolution Lipidomics of the Early Life Stages of the Red Seaweed Porphyra dioica
por: da Costa, Elisabete, et al.
Publicado: (2018)

Compartmentalization of Immune Response and Microbial Translocation in Decompensated Cirrhosis
por: Alvarez-Silva, Camila, et al.
Publicado: (2019)

Towards co‐designing active ageing strategies: A qualitative study to develop a meaningful physical activity typology for later life
por: Guell, Cornelia, et al.
Publicado: (2018)

Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis
por: Basili, Stefania, et al.
Publicado: (2019)

Human albumin infusion strategy in liver cirrhosis: liberal or restrictive?
por: Bai, Zhaohui, et al.
Publicado: (2021)

Albumin Substitution in Decompensated Liver Cirrhosis: Don’t Forget Zinc
por: Grüngreiff, Kurt, et al.
Publicado: (2021)

Albumin administration in patients with cirrhosis: Current role and novel perspectives
por: de Mattos, Ângelo Zambam, et al.
Publicado: (2022)

Expert perspectives for the pharmacist on facilitating and improving the use of albumin in cirrhosis
por: Kugelmas, Marcelo, et al.
Publicado: (2023)

Identification of indications for albumin administration in septic patients with liver cirrhosis
por: Hu, Wenhan, et al.
Publicado: (2023)

High Albumin Level Is Associated With Regression of Glucose Metabolism Disorders Upon Resolution of Acute Liver Inflammation in Hepatitis B-Related Cirrhosis
por: Tian, Caiyun, et al.
Publicado: (2022)

Biomarker Discovery for Hepatocellular Carcinoma in Patients with Liver Cirrhosis Using Untargeted Metabolomics and Lipidomics Studies
por: Rashid, Md Mamunur, et al.
Publicado: (2023)

Leveraging omics to understand the molecular basis of acute-on-chronic liver failure
por: Clària, Joan
Publicado: (2021)

La aplicación de las ómicas para comprender la base molecular de la insuficiencia hepática aguda sobre crónica
por: Clària, Joan
Publicado: (2021)

5-Lipoxygenase (5-LO) is Involved in Kupffer Cell Survival. Possible Role of 5-LO Products in the Pathogenesis of Liver Fibrosis
por: Titos, Esther, et al.
Publicado: (2004)

The significance of C-reactive protein to albumin ratio in patients with decompensated cirrhosis
por: Oikonomou, Theodora, et al.
Publicado: (2020)

Determination of Effective Albumin in Patients With Decompensated Cirrhosis: Clinical and Prognostic Implications
por: Baldassarre, Maurizio, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lmtisq7p84s1lvpl7eaniqc2d4